In 2006, Bryan et al. clearly defined TNBC as mammary cancer characterized by lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) (2). The gene discussed is ESR1; the disease is breast cancer.